Financial Metrics Exploration: Understanding Eledon Pharmaceuticals Inc (ELDN) Through Ratios

Kevin Freeman

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.56 million shares were traded. ELDN stock price reached its highest trading level at $1.64 during the session, while it also had its lowest trading level at $1.55.

Ratios:

Our analysis of ELDN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.74 and its Current Ratio is at 6.74. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

On January 28, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $9.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELDN now has a Market Capitalization of 117803800 and an Enterprise Value of 1414572.

Stock Price History:

The Beta on a monthly basis for ELDN is 0.89, which has changed by -0.63990825 over the last 52 weeks, in comparison to a change of 0.13329959 over the same period for the S&P500. Over the past 52 weeks, ELDN has reached a high of $4.98, while it has fallen to a 52-week low of $1.35. The 50-Day Moving Average of the stock is -36.11%, while the 200-Day Moving Average is calculated to be -45.57%.

Shares Statistics:

ELDN traded an average of 2.22M shares per day over the past three months and 1005440 shares per day over the past ten days. A total of 75.08M shares are outstanding, with a floating share count of 70.02M. Insiders hold about 6.75% of the company’s shares, while institutions hold 49.92% stake in the company. Shares short for ELDN as of 1764288000 were 4685209 with a Short Ratio of 2.11, compared to 1761868800 on 4281446. Therefore, it implies a Short% of Shares Outstanding of 4685209 and a Short% of Float of 6.819999999999999.

Earnings Estimates

Current recommendations for the stock of the company come from 6.0 analysts. The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.17 and low estimates of -$0.35.

Analysts are recommending an EPS of between -$0.59 and -$0.7 for the fiscal current year, implying an average EPS of -$0.63. EPS for the following year is -$0.95, with 4.0 analysts recommending between -$0.72 and -$1.31.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.